Inderal

Propranolol Hydrochloride, the active ingredient in Inderal, is a beta blocker presented as an oral tablet for oral use. It is used to manage high blood pressure, chest pain, irregular heart rhythms, migraine prevention, essential tremor, and certain endocrine tumors. GNH USA supplies Inderal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inderal is a non‑selective beta‑adrenergic antagonist that acts on cardiovascular and neurological pathways. - Hypertension: lowers blood pressure by reducing heart rate, myocardial contractility and renin release. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Cardiac arrhythmias: stabilises abnormal heart rhythms by slowing conduction through the AV node. - Migraine prophylaxis: reduces frequency of migraine attacks through vascular modulation. - Essential tremor: diminishes tremor amplitude by dampening peripheral sympathetic activity. - Pheochromocytoma: controls catecholamine‑induced hypertension during pre‑operative management.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea, stomach discomfort or diarrhea. - Sleep disturbances: insomnia or vivid dreams.

Serious or Rare Side Effects: - Bradycardia: abnormally slow heart rate that may cause fainting. - Hypotension: significant drop in blood pressure leading to dizziness or shock. - Bronchospasm: tightening of airway muscles, especially in asthmatic patients. - Heart block: impaired electrical conduction causing arrhythmias. - Severe depression or mood changes. - Allergic reactions: rash, swelling, or anaphylaxis.

Before starting Inderal, consider the following precautions: - Cardiovascular assessment: evaluate heart rate and blood pressure to ensure suitability. - Respiratory conditions: avoid in patients with active asthma or severe chronic obstructive pulmonary disease. - Diabetes monitoring: beta‑blockade can mask hypoglycaemic symptoms; check glucose levels regularly. - Thyroid disorders: use cautiously in hyperthyroidism as symptoms may be concealed. - Discontinuation: taper the dose gradually to prevent rebound hypertension or tachycardia. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Propranolol may interact with several medicines; review the following groups: Major Interactions (Avoid): - Severe asthma: non‑selective beta‑blockade can precipitate bronchospasm. - Calcium channel blockers (verapamil, diltiazem): combined effect may cause profound bradycardia or heart block. - Insulin or sulfonylureas: beta‑blockade may mask hypoglycaemia signs. Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase propranolol plasma concentrations. - Antithyroid drugs: propranolol can alter thyroid hormone levels, requiring dose adjustment. - NSAIDs: may reduce the antihypertensive efficacy of propranolol.